CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 4 Planned sale Chief Financial Officer sold 1,586 shares at $10.85 ($17,211)
- 4 Planned sale See Remarks sold 10,502 shares at $10.85 ($113,967)
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- UPLOAD Other SEC-generated Letter
- SC 13G/A Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Financial Officer sold 3,276 shares at $14.98 ($49,074)
- 4 Open-market sale Chief Marketing Officer sold 5,631 shares at $15.85 ($89,251)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Director acquired 23,014 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Executive or director change · Shareholder vote results
Page 6 of 28 · 558 filings